About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

WAKAMOTO PHARMACEUTICAL CO.,LTD.(4512) Summary

4512
TSE Standard
WAKAMOTO PHARMACEUTICAL CO.,LTD.
315
JPY
-6
(-1.87%)
Apr 16, 3:30 pm JST
2.21
USD
Apr 16, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
0.92
Yield
0.95%
Margin Trading Ratio
98.31
Stock Price
Apr 16, 2025
Opening Apr 16, 9:00 am
322 JPY 2.24 USD
Previous Close Apr 15
321 JPY 2.24 USD
High Apr 16, 9:00 am
322 JPY 2.24 USD
Low Apr 16, 2:25 pm
315 JPY 2.21 USD
Volume
181,000
Trading Value
0.06B JPY 0.40M USD
VWAP
316.86 JPY 2.23 USD
Minimum Trading Value
31,500 JPY 221 USD
Market Cap
0.01T JPY 0.08B USD
Number of Trades
241
Liquidity & Number of Trades
As of Apr 16, 2025
Liquidity
Slightly High
1-Year Average
462
1-Year High Feb 7, 2025
12,753
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 11, 2025 190,700 1,296,400 6.80
Apr 4, 2025 184,200 1,332,100 7.23
Mar 28, 2025 199,800 1,464,400 7.33
Mar 21, 2025 239,200 1,643,300 6.87
Mar 14, 2025 241,400 1,475,500 6.11
Company Profile
WAKAMOTO PHARMACEUTICAL CO.,LTD. is known for its flagship product, the digestive medicine "Kyouryoku Wakamoto". The company's revenue is primarily driven by its ophthalmology and eye drop products, with additional focus on dental clinic supplies.
Sector
Pharmaceuticals
WAKAMOTO PHARMACEUTICAL CO.,LTD. primarily operates in the pharmaceutical industry, while also engaging in healthcare, global business, and real estate leasing. In its pharmaceutical division, the company focuses on ophthalmology, offering both brand-name and generic drugs, as well as supplements. The healthcare division manufactures and sells the flagship product "Kyouryoku Wakamoto", along with the medicinal toothpaste "Avantbeads" series and feminine care products like "Femiflora". The global business division exports products such as "Wakamoto" and raw materials to Asia and Europe, while also pursuing new licensing opportunities. Domestically, the company is involved in contract manufacturing and the production and sale of diagnostic reagents and raw materials. The real estate leasing business primarily revolves around rentals related to COREDO Muromachi.